A Study of R3421 in Patients With Moderate to Severe Chronic Plaque Psoriasis.

Summary

This study will investigate the safety, efficacy and pharmacokinetics of R3421 in patients with moderate to severe chronic plaque psoriasis. Patients will be randomized to one of 3 treatment groups to receive once daily oral treatment with a)R3421 20mg, b)R3421 120mg, or c)placebo. The anticipated time on study treatment is \<3 months, and the target sample size is \<100 individuals.

Timeline

Start

2007-07

Primary completion

2009-09

Completion

2009-09

Drugs

Indications